Lindane toxicity: A comprehensive review of the medical literature

Pediatric Dermatology

Volumn 29, Issue 2, 2012, Pages 141-146

  Nolan, Katherine ^a   Kamrath, Jacqueline ^a   Levitt, Jacob ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYL ALCOHOL; CROTAMITON; IVERMECTIN; LINDANE; MALATHION; PERMETHRIN; PIPERONYL BUTOXIDE PLUS PYRETHROID; SPINOSAD; SULFUR DERIVATIVE;

ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS; ALOPECIA; ANAPHYLAXIS; APHASIA; APLASTIC ANEMIA; ATAXIA; AUTOPSY; DISEASE SEVERITY; DISORIENTATION; DRUG BRAIN LEVEL; DRUG FATALITY; DRUG LABELING; DRUG MARKETING; DRUG MISUSE; DRUG RECALL; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DYSPNEA; ENVIRONMENTAL IMPACT; FOOD AND DRUG ADMINISTRATION; HEART ARRHYTHMIA; HUMAN; INGESTION; LEUKOCYTOSIS; LIPOPHILICITY; LIVER DYSFUNCTION; MENSTRUATION DISORDER; NEUROTOXICITY; PARESIS; PEDICULOSIS CAPITIS; PRIORITY JOURNAL; REVIEW; SCABIES; SEIZURE; SYSTEMATIC REVIEW; TACHYCARDIA; TREMOR; UNSPECIFIED SIDE EFFECT; VERTIGO; VISUAL DISORDER;

ACARICIDES; FEMALE; HUMANS; INSECTICIDES; LICE INFESTATIONS; LINDANE; SCABIES;

EID: 84859110523     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2011.01519.x     Document Type: Review

References (41)

1. Solomon LM, Fahrner L, West DP,. Gamma benzene hexachloride toxicity: a review. Arch Dermatol 1977; 113: 353-357.
2. Wooltorton E,. Concerns over lindane treatment for scabies and lice. CMAJ 2003; 168: 1447-1448.
3. Dollery C,. Therapeutic Drugs. Edinburgh: Churchill Livingstone, 1999.
4. US Environmental Protection Agency. Lindane; Cancellation Order. 2006. Available at:. Accessed on October 24, 2010.
5. Humphreys EH, Janssen S, Heil A, et al., Outcomes of the California ban on pharmaceutical lindane: clinical and ecologic impacts. Environ Health Perspect 2008; 116: 297-302.
6. Michigan Legislature- House Bill 4402. 2009. Available:. Accessed on October 30, 2010.
7. US Food and Drug Administration (FDA). Lindane Assessment Memorandum. 2003. Available:. Accessed on October 25, 2010.
8. Juan WH, Yang LC, Hong HS,. Acute generalized exanthematous pustulosis induced by topical lindane. Dermatology 2004; 209: 239-240.
9. Food and Drug Administration. Warning Letter. Available at:. Accessed on February 4, 2011.
10. Danopoulos E, Melissinos K, Katsas G,. Serious poisoning by hexachlorocyclohexane. Arch Indiist Hyg Chicago 1953; 8: 582-587.
11. Davies JE, Dedhia HV, Morgade C, et al., Lindane poisonings. Arch Dermatol 1983; 119: 142-144.
12. Meinking TL, Serrano L, Hard B, et al., Comparative in vitro pediculicidal efficacy of treatments in a resistant head lice population in the United States. Arch Dermatol 2002; 138: 220-224.
13. Zhang W, Ye Y, Hu D, et al., Characteristics and transport of organochlorine pesticides in urban environment: air, dust, rain, canopy throughfall, and runoff. J Environ Monit 2010, 12: 2153-2160.
14. United States Environmental Protection Agency. Basic information about lindane in drinking water. Available at:. Updated June 14, 2010; Accessed on October 24, 2010.
15. Health Canada. Canada Vigilance Adverse Reaction Database. Available at:. Updated November 16, 2010; Accessed on February 9, 2011.
16. Center for Drug Evaluation and Research, US Food and Drug Administration. FDA public health advisory: safety of topical lindane products for the treatment of scabies and lice. Rockville (MD) 2003. Available at:. Accessed on October 25, 2010.
17. Lindane lotion, USP, 1% prescribing information. Updated March 28, 2003. Available at:. Accessed on October 25, 2010.
18. Andrews EB, Joseph MC, Magenheim MJ, et al., Postmarketing surveillance study of permethrin creme rinse. Am J Public Health 1992; 82: 857-861.
19. Rauch AE, Kowalsky SF, Lesar TS, et al., Lindane (Kwell)-induced aplastic anemia. Arch Intern Med 1990; 150: 2393-2395.
20. Centers for Disease Control and Prevention (CDC). Unintentional topical lindane ingestions United States, 1998-2003. MMWR Morb Mortal Wkly Rep 2005; 54: 533-535.
21. Vander Stichele RH, Dezeure EM, Bogaert MG,. Systematic review of clinical efficacy of topical treatments for head lice. BMJ 1995; 311: 604-608.
22. Idriss S, Levitt J,. Malathion for head lice and scabies: treatment and safety considerations. J Drugs Dermatol 2009; 8: 715-720.
23. US Food and Drug Administration. FDA Approves Benzyl Alcohol Lotion for the Treatment of Head Lice. 2009. Accessed on February 10, 2011.
24. Stough D, Shellabarger S, Quiring J, et al., Efficacy and safety of spinosad and permethrin creme rinses for pediculosis capitis (head lice). Pediatrics 2009; 124: e389-e395, Epub 2009 Aug 24.
25. Meinking TL, Villar ME, Vicaria M, et al., The clinical trials supporting benzyl alcohol lotion 5% (Ulesfia): a safe and effective topical treatment for head lice (pediculosis humanus capitis). Pediatr Dermatol 2010; 27: 19-24.
26. Strong M, Johnstone PW,. Interventions for treating scabies. Cochrane Database Syst Rev 2007; 3: CD000320.
27. Aks SE, Krantz A, Hryhorczuk DO, et al., Acute accidental lindane ingestion in toddlers. Ann Emerg Med 1995; 26: 647-651.
28. Appleby J. FDA cites toxic risk of popular head-lice drug. USA Today. 2008 Jan.
29. Berry DH, Brewster MA, Watson R, et al., Untoward effects associated with lindane abuse. Am J Dis Child 1987; 141: 125-126.
30. Fischer TF,. Lindane toxicity in a 24-year-old woman. Ann Emerg Med 1994; 24: 972-974.
31. Friedman SJ,. Lindane neurotoxic reaction in nonbullous congenital ichthyosiform erythroderma. Arch Dermatol 1987; 123: 1056-1058.
32. Hall RC,. Long term psychological and neurological complications of lindane poisoning. Psychosomatics 1999; 40: 513-517.
33. Kramer MS, Hutchinson TA, Rudnick SA, et al., Operational criteria for adverse drug reactions in evaluating suspected toxicity of a popular scabicide. Clin Pharmacol Ther 1980; 27: 149-155.
34. Lee B, Groth P,. Scabies: transcutaneous poisoning during treatment. Pediatrics 1977; 59: 643.
35. Lee B, Groth P, Turner W,. Suspected reactions to gamma benzene hexachloride. JAMA 1976; 25: 2846-2846.
36. Matsuoka LY,. Convulsions following application of gamma benzene hexachloride. J Am Acad Dermatol 1981; 5: 98-99.
37. Nordt SP, Chew G,. Acute lindane poisoning in three children. J Emerg Med 2000; 18: 51-53.
38. Pramanik AK, Hansen RC,. Transcutaneous gamma benzene hexachloride absorption and toxicity in infants and children. Arch Dermatol 1979; 115: 1224-1225.
39. Telch J, Jarvis DA,. Acute intoxication with lindane (gamma benzene hexachloride). Can Med Assoc J 1982; 6: 662-663.
40. Tenenbein M,. Seizures after lindane therapy. J Am Geriatr Soc 1991; 39: 394-395.
41. Sudakin DL,. Fatality after a single dermal application of lindane lotion. Arch Environ Occup Health 2007; 62: 201-203.